SG11201702299SA - Pharmaceutical product - Google Patents

Pharmaceutical product

Info

Publication number
SG11201702299SA
SG11201702299SA SG11201702299SA SG11201702299SA SG11201702299SA SG 11201702299S A SG11201702299S A SG 11201702299SA SG 11201702299S A SG11201702299S A SG 11201702299SA SG 11201702299S A SG11201702299S A SG 11201702299SA SG 11201702299S A SG11201702299S A SG 11201702299SA
Authority
SG
Singapore
Prior art keywords
pharmaceutical product
pharmaceutical
product
Prior art date
Application number
SG11201702299SA
Other languages
English (en)
Inventor
Shin Sugimoto
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55581239&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201702299S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kowa Co filed Critical Kowa Co
Publication of SG11201702299SA publication Critical patent/SG11201702299SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Wrappers (AREA)
SG11201702299SA 2014-09-25 2015-09-25 Pharmaceutical product SG11201702299SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014194965 2014-09-25
PCT/JP2015/077014 WO2016047720A1 (fr) 2014-09-25 2015-09-25 Produit pharmaceutique

Publications (1)

Publication Number Publication Date
SG11201702299SA true SG11201702299SA (en) 2017-04-27

Family

ID=55581239

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201702299SA SG11201702299SA (en) 2014-09-25 2015-09-25 Pharmaceutical product

Country Status (13)

Country Link
US (1) US20170266080A1 (fr)
EP (1) EP3199162B1 (fr)
JP (5) JP6236167B2 (fr)
KR (2) KR20180021929A (fr)
CN (1) CN107073012A (fr)
BR (1) BR112017006148A2 (fr)
CA (1) CA2962624C (fr)
ES (1) ES2909876T3 (fr)
MX (1) MX2017003943A (fr)
MY (1) MY179721A (fr)
SG (1) SG11201702299SA (fr)
TW (1) TWI686198B (fr)
WO (1) WO2016047720A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106794186B (zh) * 2014-09-25 2020-06-05 兴和株式会社 医药制剂
JP7125250B2 (ja) * 2016-04-22 2022-08-24 ロート製薬株式会社 眼科組成物
JP7159501B1 (ja) * 2016-04-22 2022-10-24 ロート製薬株式会社 眼科組成物
JP7153999B2 (ja) * 2016-04-22 2022-10-17 ロート製薬株式会社 水性組成物
EP3446682B1 (fr) * 2016-04-22 2021-05-26 Rohto Pharmaceutical Co., Ltd. Composition ophtalmique
JP7387835B2 (ja) * 2016-04-22 2023-11-28 ロート製薬株式会社 眼科組成物
JP2017197526A (ja) * 2016-04-22 2017-11-02 ロート製薬株式会社 眼科組成物
JP2017197524A (ja) * 2016-04-22 2017-11-02 ロート製薬株式会社 眼科組成物
US11331390B2 (en) 2016-04-22 2022-05-17 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
JP2017226651A (ja) * 2016-06-15 2017-12-28 興和株式会社 水性なる組成物
CN110366416A (zh) * 2017-02-28 2019-10-22 兴和株式会社 医药
WO2018159700A1 (fr) * 2017-02-28 2018-09-07 興和株式会社 Préparation pharmaceutique
EP3590515A4 (fr) * 2017-02-28 2020-12-23 Kowa Company, Ltd. Produit médicamenteux
WO2018181294A1 (fr) * 2017-03-27 2018-10-04 興和株式会社 Préparation pharmaceutique
WO2019167183A1 (fr) * 2018-02-28 2019-09-06 興和株式会社 Préparation pharmaceutique

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101194123B1 (ko) * 2004-03-16 2012-10-24 아사히 가세이 파마 가부시키가이샤 패수딜 함유 제제 및 그 안정성을 개선하는 방법
TWI367098B (en) * 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
JP2006290827A (ja) * 2005-04-13 2006-10-26 Kowa Co 緑内障予防又は治療剤
JP4800720B2 (ja) * 2005-09-21 2011-10-26 興和株式会社 点眼用組成物
US20080064681A1 (en) * 2006-09-11 2008-03-13 Hiroyoshi Hidaka Therapeutic agent for treating glaucoma
CN102099037A (zh) * 2008-07-25 2011-06-15 旭化成制药株式会社 含有磺酰胺化合物的稳定的水溶液组合物
WO2015156321A1 (fr) * 2014-04-09 2015-10-15 ロート製薬株式会社 Composition ophtalmique
CN106794186B (zh) * 2014-09-25 2020-06-05 兴和株式会社 医药制剂
JP5951921B1 (ja) * 2014-12-12 2016-07-13 興和株式会社 組成物

Also Published As

Publication number Publication date
TW201613602A (en) 2016-04-16
CA2962624A1 (fr) 2016-03-31
EP3199162A1 (fr) 2017-08-02
MX2017003943A (es) 2017-06-30
US20170266080A1 (en) 2017-09-21
KR101860279B1 (ko) 2018-05-21
KR20170063572A (ko) 2017-06-08
JPWO2016047720A1 (ja) 2017-06-29
CA2962624C (fr) 2022-08-30
WO2016047720A1 (fr) 2016-03-31
ES2909876T3 (es) 2022-05-10
JP2021107462A (ja) 2021-07-29
JP2018021077A (ja) 2018-02-08
EP3199162A4 (fr) 2018-04-25
TWI686198B (zh) 2020-03-01
JP2023041805A (ja) 2023-03-24
CN107073012A (zh) 2017-08-18
MY179721A (en) 2020-11-11
BR112017006148A2 (pt) 2017-12-26
KR20180021929A (ko) 2018-03-05
JP6236167B2 (ja) 2017-11-22
EP3199162B1 (fr) 2022-03-09
JP2019199483A (ja) 2019-11-21

Similar Documents

Publication Publication Date Title
IL270954A (en) Pharmaceutical compounds
GB201610184D0 (en) Product
SG11201702299SA (en) Pharmaceutical product
GB201509055D0 (en) New product
GB201502721D0 (en) Product
GB201404922D0 (en) Pharmaceutical compounds
GB201522232D0 (en) Combination product
SG11201702298VA (en) Pharmaceutical preparation
GB201416513D0 (en) Pharmaceutical compounds
GB201417707D0 (en) Pharmaceutical compounds
GB201409250D0 (en) New product
GB201410384D0 (en) Confectionary product
GB201517632D0 (en) New product
GB201420311D0 (en) Pharmaceutical processing
IL250160A0 (en) medicinal substance
SI3236952T1 (sl) Farmacevtski sestavek v obliki tablet
GB201614651D0 (en) Product
GB201604619D0 (en) Product
GB201513553D0 (en) Product
GB201508022D0 (en) Pharmaceutical compounds
GB201402745D0 (en) Product
GB201411770D0 (en) Products
GB201411148D0 (en) New pharmaceutical uses
GB201416969D0 (en) Pharmaceutical compounds
GB201416968D0 (en) Pharmaceutical compounds